Tuesday, September 24, 2019
- 1:45pm-3:15pm
-
Technology-based assessment of motor impairment in de novo Parkinson’s disease patients: implications for diagnostic accuracy and early identification of distinct phenotypes
Classification of Movement Disorders · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
The association between frailty and Parkinson’s in the ReSPOnD trial
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
The carotid ultrasonography revealed vagus nerve atrophy of the patients with parkinsonism
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
The Chinese Parkinson’s disease Registry scheme
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
The congruence of asymmetry between motor symptoms and retinal thickness in Parkinson’s disease
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
The contribution of cerebrovascular risk factors, metabolic and inflammatory changes to cognitive decline in Parkinson’s disease
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
The differential role of subthalamic and nigral neurons in gait control in Parkinson´s disease patients
Neurophysiology · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
The Dutch Parkinson and Microbiome Study (DUPARM): Gut Microbiome Composition of Treatment-Naïve De Novo Parkinson’s Disease Patients
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
The Dutch Yips Study
Dystonia · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
The effect of active contact localization on motor symptoms in deep brain stimulation of the subthalamic nucleus for Parkinson’s disease
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- «Previous Page
- 1
- …
- 59
- 60
- 61
- 62
- 63
- …
- 69
- Next Page»